Cancer Doctors Map Female Anatomy to Protect Sexual Health

For decades, radiation oncologists have carefully mapped and protected male sexual organs during pelvic cancer treatment, but female sexual anatomy has remained largely invisible in those same treatment plans.

Now, researchers at Mount Sinai's Icahn School of Medicine have published the first practical guide to change that. Their study gives doctors step-by-step instructions to identify and protect the bulboclitoris, a female erectile organ crucial for sexual arousal and orgasm, during lifesaving radiation therapy.

"Compared to male sexual anatomy, female erectile structures have been largely invisible in standard radiation workflows," said Dr. Deborah Marshall, the study's senior author and Assistant Professor of Radiation Oncology. "Our goal was to provide clinicians with a practical anatomy-grounded way to change that."

The research team combined anatomic dissection, detailed imaging, and current scientific knowledge to create clear guidelines. They demonstrated how doctors can identify these structures on standard CT and MRI scans already used in treatment planning, making it feasible to measure radiation exposure and link it to sexual health outcomes.

The bulboclitoris isn't just an external structure. It's an entire internal organ made of erectile tissues located just outside the pelvis, and radiation exposure during cancer treatment can affect arousal, sensation, orgasm, and overall sexual function.

Until now, sexual function outcomes after pelvic radiotherapy have been significantly understudied in women. This gap has limited doctors' ability to counsel patients, prevent side effects, and provide equitable care compared to male cancer survivors.

The study, published in Practical Radiation Oncology, involved researchers from seven leading institutions including MIT, Memorial Sloan Kettering, and NYU Langone. It establishes a standardized approach that enables routine measurement and dose reporting, just like doctors already do for other organs at risk during radiation.

Why This Inspires

This research represents something bigger than improved medical imaging. It's about recognizing female sexual health and pleasure as legitimate, important components of cancer survivorship worth protecting.

For patients, the work means more informed conversations about potential side effects and more personalized treatment planning. Doctors now have tools to minimize radiation dose to these organs when medically appropriate, using an "as low as reasonably achievable" approach.

The team's next steps include prospective research through Mount Sinai's STAR program and improved patient-reported outcome measures that reflect diverse sexual experiences.

After years of being overlooked, female sexual anatomy finally has a seat at the treatment planning table.